Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763546019 | Nystatin 200000 unit oromucosal lozenge | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3763547011 | Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing nystatin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Skin antifungal agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Nystatin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has manufactured dose form | Conventional release oromucosal lozenge | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has unit of presentation | Lozenge | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has basis of strength substance | Nystatin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator unit | Unit | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength denominator unit | Lozenge | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has presentation strength numerator value | 200000 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Has precise active ingredient | Nystatin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Is a | Product containing only nystatin in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely nystatin 200000 unit/1 each conventional release oromucosal lozenge (clinical drug) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR